The host environment determines strain-specific differences in the timing of skeletal muscle regeneration: cross-transplantation studies between SJL/J and BALB/c mice

Journal of Anatomy
P RobertsM D Grounds

Abstract

The difference in the timing of the regeneration process of skeletal muscle between SJL/J and BALB/c mice was investigated using grafts of whole skeletal muscle (both autografts and allografts). Histological, autoradiographic and immunohistochemical techniques were used in the investigation. Infiltration of leucocytes into autografts, numbers of desmin-positive myogenic cells and myotube formation were all more advanced in the SJL/J compared with BALB/c mice. Furthermore, autoradiographic evidence showed that myoblasts in the SJL/J autografts were synthesising DNA 12 h earlier than myoblasts in BALB/c autografts. In allografts, where SJL/J host mice received BALB/c grafts, and vice versa, leucocyte infiltration and myotube formation occurred earlier in the BALB/c muscles grafted into SJL/J hosts, than in the reverse situation with BALB/c hosts. The results show that, at least for whole muscle grafts, it is the host environment which determines the speed and outcome of the regenerative process.

References

Apr 1, 1979·Journal of the Neurological Sciences·F M Hansen-Smith, B M Carlson
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S J Kaufman, R F Foster
Aug 1, 1983·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·R Dilley, J McGeachie
Nov 1, 1995·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J G Cannon
Feb 1, 1995·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S R ShiC R Taylor
Dec 1, 1994·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·P Evers, H B Uylings

❮ Previous
Next ❯

Citations

Mar 14, 2002·The American Journal of Pathology·Christine A KostekJeffrey Boone Miller
Dec 12, 2001·Neuromuscular Disorders : NMD·K Leriche-GuérinJ P Tremblay
May 7, 1999·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·A B Borisov
Feb 3, 1999·Annals of the New York Academy of Sciences·M D Grounds
Mar 26, 2009·Regenerative Medicine·Barbara Gayraud-MorelShahragim Tajbakhsh
Mar 12, 2013·Neuromuscular Disorders : NMD·Mark A HornseyKate Bushby
Feb 28, 2016·Molecular Aspects of Medicine·Pedro Sousa-Victor, Pura Muñoz-Cánoves
Dec 5, 2015·Frontiers in Physiology·Terence E RyanJoseph M McClung
Apr 2, 2014·The American Journal of Pathology·Miranda D GroundsTea Shavlakadze
Mar 5, 2013·The FEBS Journal·Laura García-PratPura Muñoz-Cánoves
Dec 9, 2014·Cell Cycle·Pedro Sousa-VictorPura Muñoz-Cánoves
Jul 30, 2005·The Journal of Surgical Research·Paula K Shireman, Marlon P Quinones
Apr 15, 2015·Trends in Endocrinology and Metabolism : TEM·Pedro Sousa-VictorPura Muñoz-Cánoves
Mar 26, 2013·Biochimica Et Biophysica Acta·Mark RomanickHolly M Brown-Borg
Oct 19, 2000·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J D WhiteM D Grounds
Aug 22, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ying WangJames G Tidball
Jan 13, 2004·Physiological Reviews·Sophie B P Chargé, Michael A Rudnicki
Dec 28, 2018·Npj Regenerative Medicine·Brendan Evano, Shahragim Tajbakhsh
Jul 18, 2001·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·R A Collins, M D Grounds
Nov 12, 2015·Frontiers in Physiology·Tim SnijdersGianni Parise
Jun 21, 2019·Journal of Molecular Histology·Renata IshibaMariz Vainzof

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.